Four Drugmakers Must Face Lawsuit Over Drug Overcharges

A U.S. appeals court revived a lawsuit accusing four major drugmakers of overcharging for medications. The case claims the firms defrauded the U.S. government.

Xurve View
洞察:

A federal appeals court in the United States has reinstated a whistleblower lawsuit against four major pharmaceutical companies. The legal action accuses AbbVie Inc., AstraZeneca PLC, NOVARTIS AG-2ND LINE, and Sanofi of defrauding government programs by overcharging for medications intended for low-income and uninsured patients.

An illustration featuring U.S. dollar banknotes and various medications, captured on June 27, 2024. REUTERS/Dado Ruvic/Illustration
IUX24

IUX24 提供深度財經、經濟與投資資訊,借助 AI 挖掘全球市場中最重要的訊號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場資料、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易訊號或經紀服務。投資涉及風險,使用者在做出投資決定前應審慎評估相關資訊。